Fulvestrant in heavily pre-treated patients with advanced breast cancer: results from a single compassionate use programme centre-Reference-Cited by-同舟云学术

Fulvestrant in heavily pre-treated patients with advanced breast cancer: results from a single compassionate use programme centre

Published:2007-01-27 Issue:1 Volume:106 Page:97-103
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Catania Chiara,Ascione Gilda,Adamoli Laura,De Pas Tommaso,Medici Marta,Franceschelli Lucia,Verri Elena,Magni Elena,Sanna Giuseppina,Torrisi Rosalba,Goldhirsch Aron,Nolè Franco

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-006-9481-8.pdf

Reference21 articles.

1. Goldhirsch A, Gelber R (1996) Endocrine therapies of breast cancer. Semin Oncol 23:494–505

2. Hortobagyi GN (1998) Progress in endocrine therapy for breast carcinoma. Cancer 83:1–6

3. Buzdar AU, Hortobagyi G (1998) Update on endocrine therapy for breast cancer. Clin Cancer Res 4:527–534

4. Johnston SR, Martin AL, Dowset M (2005) Life following aromatase inhibitors: where now for endocrine sequencing? Breast Cancer Res Treat 93(Suppl 1):S19–S25

5. Howell A, Osborne CK, Morris C et al (2000) ICI 182,780 (Faslodex): development of a novel, “pure” antiestrogen. Cancer 89:817–825

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintenance Therapy in Metastatic Solid Tumors;American Journal of Clinical Oncology;2019-08

2. A pilot study of cabergoline for the treatment of metastatic breast cancer;Breast Cancer Research and Treatment;2017-07-03

3. Fulvestrant in hormonal treatment of breast cancer;ONCOL CLIN PRACT;2017

4. Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review;Future Oncology;2016-05

5. Models and mechanisms of acquired antihormone resistance in breast cancer: significant clinical progress despite limitations;Hormone Molecular Biology and Clinical Investigation;2012-01-01